3 September 2020 (Thursday) -Transfusion News Update

The nice people at “Transfusion News” sent their update today:

High-throughput Blood Antigen Array Genotyping for Blood Donors

September 1, 2020 Alloimmunization to red blood cell (RBC), human leukocyte (HLA), and human platelet (HPA) antigens can lead to hemolytic transfusion reactions and lower increments. Researchers with the Blood Transfusion Genomics Consortium have developed a high-throughput, genome-wide blood donor antigen typing system to analyze [Read More]

FDA Issues Emergency Use Authorization for COVID-19 Convalescent Plasma

August 25, 2020 To increase access to COVID-19 convalescent plasma (CCP) use, President Trump, in conjunction with the U.S. FDA, announced Emergency Use Authorization (EUA) for CCP on August 23, 2020. CCP has been available in the U.S. since early April through the Expanded Access Program (EAP)—a program sponsored by [Read More]

Follow us on Twitter @Transfusion News